Two separate prospective clinical studies have both demonstrated that pancreatic cancer patients with low tumor hENT1 staining have significantly reduced disease-free survival and overall survival (approximately 2- to 3- fold) compared to patients with high hENT1 tumor staining [6], [8]. The gene discussed is SLC29A1; the disease is pancreatic neoplasm.